Purchase Short-Term Access
In hemodialysis patients with CHF, adding telmisartan to standard ACE inhibitors reduced CHD mortality and admissions
Reem Mustafa, MD, MPH; Amit X. Garg, MD, PhD
Annals of Internal Medicine 2011;154:JC5-5.
doi:10.7326/0003-4819-154-10-201105170-02005
Purchase Online access to this article for 24 hours
